What This New Study Found Between Semaglutide (Ozempic, Wegovy), Tirzepatide (Mounjaro, Zepbound), and Stroke Risk A new cohort study published July 2025 in JAMA Network Open followed over 60,000 adults with both type 2 diabetes and obesity
A structured maintenance plan can help reduce regain risk, but no approach guarantees complete stability
They can have side effects, ranging from common nausea to more serious, though rare, complications
Optavia Fuelings are Optavia-branded meal preps that are high in protein, contain added probiotics, low in carbs and calories
cAMP activates PKA, which in turn activates MAPK/ERK anti-inflammatory signaling and also activates and phosphorylates the transcription factor CREB (Jolivalt et al